Dietary selenium and major depression: A nested case-control study

Pasco, Julie A., Jacka, Felice N., Williams, Lana J., Evans-Cleverdon, Melinda, Brennan, Sharon L., Kotowicz, Mark A., Nicholson, Geoffrey C., Ball, Madeleine J. and Berk, Michael (2012) Dietary selenium and major depression: A nested case-control study. Complementary Therapies in Medicine, 20 3: 119-123. doi:10.1016/j.ctim.2011.12.008

Author Pasco, Julie A.
Jacka, Felice N.
Williams, Lana J.
Evans-Cleverdon, Melinda
Brennan, Sharon L.
Kotowicz, Mark A.
Nicholson, Geoffrey C.
Ball, Madeleine J.
Berk, Michael
Title Dietary selenium and major depression: A nested case-control study
Journal name Complementary Therapies in Medicine   Check publisher's open access policy
ISSN 0965-2299
Publication date 2012-06
Sub-type Article (original research)
DOI 10.1016/j.ctim.2011.12.008
Volume 20
Issue 3
Start page 119
End page 123
Total pages 5
Place of publication Kidlington, United Kingdom
Publisher Churchill Livingstone
Collection year 2013
Language eng
Formatted abstract
Objectives and methods: Alterations in redox biology are established in depression; however, there are no prospective epidemiological data on redox-active selenium in depression. We aimed to determine if low levels of dietary selenium are associated with an increased risk for de novo major depressive disorder (MDD). In this nested case-control study, women aged 20 years or more were identified from a randomly selected cohort being followed prospectively for the Geelong Osteoporosis Study. Cases were individuals with incident MDD, identified using the Structured Clinical Interview for DSM-IV-TR (SCID-I/NP); controls had no such history. Dietary selenium intake was measured using a food frequency questionnaire at baseline, together with anthropometric and lifestyle measures.
Results: Eighteen women who developed de novo MDD were classified as cases; there were 298 controls. Low dietary selenium intakes increased the likelihood of developing MDD; OR 2.74 (95%CI 0.95—7.89). After adjusting for age and SES, compared with a high selenium intake, a low intake (<8.9 μg/MJ/day) was associated with an approximate trebling of the likelihood for developing de novo MDD; OR 2.95 (95%CI 1.00—8.72). Smoking, alcohol consumption and physical activity did not confound the association.
Conclusion: These data suggest that lower dietary selenium intakes are associated with an increased risk of subsequent de novo MDD. We propose that selenium’s function as an antioxidant, and as a constituent of selenoproteins that are important in redox homeostasis, warrants further investigation as a risk factor for depression, and suggest a potentially novel modifiable factor in the primary prevention and management of depression.

Keyword Antioxidant
Major depressive disorder
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Official 2013 Collection
School of Medicine Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 20 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 26 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Mon, 28 May 2012, 21:05:13 EST by System User on behalf of Rural Clinical School - South West Qld Region